Global Intravenous Immunoglobulin Market Expected to Exceed USD 34.2 Billion by 2031 Due to Increasing Immunodeficiency and Autoimmune Diagnoses

[London, 27th June 2025] – Clearview Market Insights (CVMI) forecasts the global intravenous immunoglobulin (IVIG) market will expand from USD 16.4 billion in 2024 to USD 34.2 billion by 2031, reflecting a CAGR of 11.2%. The increase in immune-mediated disorders, growing neurological indications, and advancements in plasma collection are driving this growth.

IVIG has become an essential immunomodulatory therapy—especially for patients with chronic neurological and hematologic autoimmune conditions,” said Dr. Ingrid Thomas, immunotherapy analyst at CVMI.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-intravenous-immunoglobulin-market/

Key Market Insights

  • 2024 Market Size: USD 16.4 billion
  • 2031 Forecast: USD 34.2 billion
  • CAGR: 11.2% (2024–2031)

Growth Catalysts

  • Expanding Neurological Indications: CIDP and Guillain-Barré syndrome drive volume
  • Infrastructure Expansion: Global donor and plasma fractionation center growth
  • Payer Alignment: Reimbursement bolstering adoption in developed markets

Segment Trends

  • Leading Use: Primary Immunodeficiency remains core application
  • High-Growth Segment: Neurology indications, especially CIDP and MG
  • Regional Trend: North America holds >40% share; APAC emerging via specialty care access

Top Competitors (2024)

  • Takeda – 28%: Gammagard® and portfolio strength in the U.S. and Japan
  • Grifols – 23%: Strong presence in the EU and LATAM.
  • CSL Behring – 21%: Privigen® and subcutaneous alternatives are expanding rapidly.
  • Octapharma – 14%: Making strides in neurology and PIDs
  • Others – 14%: Regional brands are gaining a foothold through affordability.

Looking Ahead to 2031

Future trends encompass AI-assisted dosing protocols, global donor traceability, and next-generation liquid-stable IVIGs. The resilience of supply, affordability, and home-infusion infrastructure will determine competitive success.

 

 

For more insights, visit https://clearviewmarketinsights.com/

 

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

 

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369

Comments

Popular posts from this blog

Asia-Pacific Veterinary Equipment and Disposables Market to Surpass USD 1.85 Billion by 2032, Driven by Rising Pet Adoption and Veterinary Infrastructure Development

Middle East and Africa Pig Launchers and Receivers Market to Reach USD 141.3 Million by 2030 Amid Expanding Pipeline Networks and Maintenance Priorities

Europe Veterinary Equipment and Disposables Market to Reach USD 1.47 Billion by 2032, Fueled by Rising Pet Healthcare Demand and Technological Advancements